Loading clinical trials...

UNKNOWNNA

The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy

NCT04308343•Assiut University

Summary

The aim of this study is to : 1. Use of the aromatase inhibitor( letrozole) for the treatment of ectopic pregnancy compared to methotrexate. 2. Use of the Gnrh antagonist for the treatment of ectopic pregnancy compared to methotrexate.

Eligibility

Age

18 - 40 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Patients who have undisturbed ectopic pregnancy .Who are:
•1. have no significant pain
•2. have an unruptured tubal ectopic pregnancy with an adnexal mass smaller than 35mm with no visible heartbeat
•3. have a serum human chorionic gonadotropins level less than 1,500 IU/litre
•4. do not have an intrauterine pregnancy (as confirmed on an ultrasound scan) .

Exclusion Criteria

•1. An undisturbed ectopic pregnancy and significant pain
•2. An undisturbed ectopic pregnancy with an adnexal mass of 35 mm or larger
•3. An undisturbed ectopic pregnancy with a fetal heartbeat visible on an ultrasound scan
•4. An undisturbed ectopic pregnancy and a serum human chorionic gonadotropins level of 5,000 IU/litre or more
•5. intrauterine pregnancy

Key Dates

Start Date

March 30, 2020

Primary Completion Date

March 1, 2022

Completion Date

September 1, 2022

Last Updated

March 16, 2020

Enrollment

120

ESTIMATED participants

Conditions

Ectopic Pregnancy

Interventions

Methotrexate

DRUG

Letrozole

DRUG

cetrotide

DRUG

Contacts

Ali Saber Ali, M.Sc

CONTACT

01095567589 kenous87@yahoo.com

Reproductive Health Education, Birth Control and Sexual Quality of Life in Ectopic Pregnancy

NCT07431411

Ectopic Pregnancy

View study

NOT_YET_RECRUITING

Psychatric Effect of Ectopic Pregnancy

NCT06721403

Ectopic Pregnancy

View study

COMPLETED

Relationship Between Ectopic Pregnancy and Thyroid Disorders

NCT05446012

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 16, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy

Inclusion Criteria

Exclusion Criteria

Reproductive Health Education, Birth Control and Sexual Quality of Life in Ectopic Pregnancy

Psychatric Effect of Ectopic Pregnancy

Relationship Between Ectopic Pregnancy and Thyroid Disorders

Assessment of Biomarkers in Ectopic Pregnancy

Evaluation of Different Doses of Letrozole in Ectopic Pregnancy

Laparascopy Versus Laparatomy in the Management of Ruptured Ectopic Pregnancy